Skip to main content
. 2020 Jul 20;9(7):424. doi: 10.3390/antibiotics9070424

Table 1.

Population characteristics in 36 patients with obstructive lung diseases and non-tuberculous mycobacteria (NTM) respiratory isolates.

Factor Total Population
No. 36
NTM-LD
No. 17
Colonization
No. 19
p
Gender
Males/Females
15/21 7/10 8/11 0.95
Age, mean (SD) 65, 9 (11,6) 65, 2 (11,1) 66, 3 (12,2) 0.85
BMI, mean (SD) 24, 5 (4,8) 21, 9 (3,8) 26, 8 (4,5) 0.001
≤22.5 No (%) 14 (39) 10 (59) 4 (21) 0.04
Smoking/pack-years
median (range)
20 (0–80) 25 (0–50) 20 (0–80) 0.22
Inhaled CS No. (%) 25 (69) 12 (71) 13 (68) 0.82
Oral CS No. (%) 5 (14) 2 (12) 3 (16) 0.89
Spirometry (median, range)
FEV1%/FVC 0.51 (0.3–0.86) 0.45 (0.3–0.75) 0.56 (0.41–0.86) 0.09
FEV1% pred. 50 (22–123) 45 (22–123) 57 (34–110) 0.41
FVC% pred. 77.5 (49–129) (52–129) (49–106) 0.48
Weight loss > 5% No (%) 6 (17) 4 (24) 2 (11) 0.38
Elevated body temperature (>38 °C)
No. (%)
11 (31) 9 (53) 2 (11) 0.02
Dyspnea No. (%) 26 (72) 13 (77) 13 (68) 0.87
Haemoptysis No. (%) 8 (22) 4 (24) 4 (21) 0.82
Expectoration No. (%) 17 (47) 7 (41) 10 (53) 0.72
Bronchiectasis No. (%) 16 (44) 7 (41) 11 (58) 0.5
Hypothyreosis No. (%) 7 (19) 3 (18) 4 (21) 0.87
Past neoplastic disease No. (%) 6 (17) 4 (24) 2 (11) 0.55
Diabetes No. (%) 6 (17) 5 (29) 1 (5) 0.14

BMI—body mass index, CS—corticosteroids, FEV1—forced expiratory volume in one second, FVC—forced vital capacity, FEV1/FVC—Tiffeneau-Pinelli index.